Management of Elderly COVID-19 Patients with Cough When Paxlovid is Not an Option
For elderly COVID-19 patients with cough who cannot take Paxlovid, the next best treatment option is remdesivir, combined with supportive care including codeine for cough suppression and appropriate symptomatic management. 1
First-Line Alternative to Paxlovid
Remdesivir
- Recommended for hospitalized patients not requiring invasive mechanical ventilation
- Should be initiated as soon as possible after diagnosis
- Standard dosing for adults: 200mg IV loading dose on Day 1, followed by 100mg IV daily for 4 days
- For elderly patients, consider dose adjustment:
- Ages 60-80: 3/4-4/5 of standard adult dosing
- Ages >80: 1/2 of standard adult dosing 1
- Monitor hepatic function and prothrombin time before starting and during treatment 2
- Not recommended for patients already requiring invasive mechanical ventilation 1
Symptomatic Management for Cough
Cough Suppression
- First try simple measures: encourage patient to avoid lying on their back to make coughing more effective 1
- Consider honey for patients over 1 year of age 1
- For distressing cough, consider short-term use of:
- Codeine linctus
- Codeine phosphate tablets
- Morphine sulfate oral solution 1
Positioning Techniques
- Sitting upright increases peak ventilation and reduces airway obstruction
- Leaning forward with arms bracing a chair or knees with upper body supported improves ventilatory capacity 1
Additional Supportive Care
Managing Fever
- Advise regular fluid intake (no more than 2L/day) to avoid dehydration
- Use paracetamol for fever and associated symptoms
- Avoid NSAIDs unless clearly indicated 1
Managing Breathlessness
- Implement controlled breathing techniques:
- Pursed-lip breathing: inhale through nose for several seconds, exhale slowly through pursed lips for 4-6 seconds
- Relaxing shoulders to reduce hunched posture from anxiety
- Breathing retraining exercises 1
Special Considerations for Elderly Patients
Medication Management
- Reduce polypharmacy appropriately
- Adjust drug doses according to organ function and potential drug interactions
- Use medications with lowest risk of drug-drug interactions 1
- Use minimum effective doses for shortest duration 1
Monitoring and Prevention
- Closely monitor for potential complications:
- Secondary infections (monitor respiratory pathogens)
- Disseminated intravascular coagulation (monitor D-dimer and coagulation indicators)
- Perform timely interventions for any complications 1
Important Caveats and Pitfalls
- Remdesivir must be administered intravenously, requiring appropriate healthcare setting
- Drug interactions are common in elderly patients - review all medications before starting any treatment
- Avoid lopinavir-ritonavir as evidence shows no benefit and potential for harm 1
- Elderly patients are more susceptible to adverse drug effects due to decreased liver and kidney function
- Ensure treatment escalation plans are in place as patients with COVID-19 may deteriorate rapidly 1
- Consider advance care plans or advance decisions to refuse treatment if applicable 1
By following this algorithm, clinicians can provide effective treatment for elderly COVID-19 patients with cough when Paxlovid is not an option, focusing on both antiviral therapy and symptomatic management to improve outcomes.